Actually, you have that wrong. Without a profit motive, neither of these drugs would exist (and no, the NIH didn't develop them to marketability). The triumph is that we finally have drugs that can eradicate the virus from the patients system. It would be more honest for the manufacturer to simply not make the drug available in developing countries. For political reasons, they decide to give the drug away for free overseas, but that doesn't really have anything to do with how much or little they should collect here.